PHP4 CANADIAN COMPETION DURING A U.S. GENERIC DRUG'S 180-DAY EXCLUSIVITY PERIOD
KM Richards, MD ShepherdVolume:
10
Year:
2007
Language:
english
DOI:
10.1016/s1098-3015(10)65282-5
File:
PDF, 90 KB
english, 2007